3-Hydroxyisobutyrate dehydrogenase (HIBADH) deficiency-A novel disorder of valine metabolism.

November 08, 2021

Meyer M1, Hollenbeck JC2, Reunert J1, Seelhöfer A1, Rust S1, Fobker M3, Biskup S4, Och U1, Linden M5, Sass JO2, Marquardt T1


3-Hydroxyisobutyric acid (3HiB) is an intermediate in the degradation of the branched-chain amino acid valine. Disorders in valine degradation can lead to 3HiB accumulation and its excretion in the urine. This article describes the first two patients with a new metabolic disorder, 3-hydroxyisobutyrate dehydrogenase (HIBADH) deficiency, its phenotype and its treatment with a low-valine diet. The detected mutation in the HIBADH gene leads to nonsense-mediated mRNA decay of the mutant allele and to a complete loss-of-function of the enzyme. Under strict adherence to a low-valine diet a rapid decrease of 3HiB excretion in the urine was observed. Due to limited patient numbers and intrafamilial differences in phenotype with one affected and one unaffected individual, the clinical phenotype of HIBADH deficiency needs further evaluation.

Keywords:3-hydroxyisobutyrate dehydrogenase; 3-hydroxyisobutyrate dehydrogenase deficiency; 3-hydroxyisobutyric aciduria; HIBADH; HIBADH deficiency; branched-chain amino acids; valine degradation.